Ganymed Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
News Dec 26, 2013
Ganymed Pharmaceuticals AG has announced that it will present at the 32nd Annual J.P. Morgan Healthcare Conference that will take place from January 13 to January 16, 2014 in San Francisco.
Ganymed’s CEO, Dr. Özlem Türeci, will provide an overview of the company’s product pipeline and clinical programs. Her presentation will take place on Tuesday January 14 from 11:30 to 12:00 Pacific Time in the Elizabethan D meeting room of the Westin St. Francis Hotel, San Francisco.
The Annual J.P. Morgan Healthcare Conference is the largest healthcare investment conference, bringing together established industry leaders and emerging fast-growth companies.
High Fruit and Veg Consumption May Reduce Breast Cancer RiskNews
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.READ MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Why Might Super-Tasters be at Higher Cancer Risk?News
High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been tracked for about 20 years.READ MORE